Clinical Trial Update: Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors [Phase 1, Phase 2]

View source ↗

Summary

A combined Phase 1/2 trial evaluating Zactima with Temodar during radiation for newly diagnosed stage IV brain tumors (glioblastoma multiforme and gliosarcoma) …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme
• Gliosarcoma

Drugs mentioned

• Temodar (Temozolomide)
• Zactima (vandetanib)

Snippet

Sponsor: Patrick Y. Wen, MD | Conditions: Glioblastoma Multiforme, Gliosarcoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-03-02